tariquidar has been researched along with midostaurin in 1 studies
Studies (tariquidar) | Trials (tariquidar) | Recent Studies (post-2010) (tariquidar) | Studies (midostaurin) | Trials (midostaurin) | Recent Studies (post-2010) (midostaurin) |
---|---|---|---|---|---|
210 | 16 | 138 | 491 | 36 | 286 |
Protein | Taxonomy | tariquidar (IC50) | midostaurin (IC50) |
---|---|---|---|
Aurora kinase A | Homo sapiens (human) | 0.08 | |
Macrophage colony-stimulating factor 1 receptor | Homo sapiens (human) | 0.142 | |
Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.109 | |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.25 | |
Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.1663 | |
Aspartyl/asparaginyl beta-hydroxylase | Homo sapiens (human) | 7.5767 | |
AP2-associated protein kinase 1 | Homo sapiens (human) | 0.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cocker, HA; Kelland, LR; Pinkerton, CR; Pritchard-Jones, K; Tiffin, N | 1 |
1 other study(ies) available for tariquidar and midostaurin
Article | Year |
---|---|
In vitro prevention of the emergence of multidrug resistance in a pediatric rhabdomyosarcoma cell line.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Cisplatin; Cyclosporins; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Indomethacin; Inhibitory Concentration 50; Piperidines; Pyridines; Quinolines; Razoxane; Rhabdomyosarcoma; RNA, Neoplasm; Staurosporine; Time Factors; Tumor Cells, Cultured; Vincristine | 2001 |